P4.4 Disease outcomes: What matters to whom as AD progresses? Relevant outcomes in disease progression. Tania Dussey: Policy and industry reflections on ROADMAPs outcome definition work
This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 116020 (“ROADMAP”). This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.